DB
Dale Bryant
University College London, King's College London and Pfizer's Neusentis Unit, King's College London, University of Portsmouth
0000-0002-4783-4796
Employment
-
University College London Research Associate2015 - Present
Education
-
King's College London and Pfizer's Neusentis Unit PhD Stem Cell Biology2010 - 2014
-
King's College London MSc Neuroscience (Developmental Neurobiology)2009 - 2010
-
University of Portsmouth BSc Psychology2006 - 2009
Projects & Funding
Projects & funding information is unavailable.
Publications (11)
- Cholesterol Pathway Gene Variants and Reduced Keratinocyte Cholesterol Support a Final Common Druggable Pathway in Hyperproliferative Inflammatory Skin Diseases Save
- High-Throughput Drug Screening in a Cellular Model of KRAS-Driven Arteriovenous Malformations Save
- RNA Therapy for Oncogenic NRAS-Driven Nevi Induces Apoptosis Save
- GNAQ/GNA11 Mosaicism Causes Aberrant Calcium Signaling Susceptible to Targeted Therapeutics Save
- Mosaic BRAF Fusions Are a Recurrent Cause of Congenital Melanocytic Nevi Targetable by MAPK Pathway Inhibition Save
- The timing of auditory sensory deficits in Norrie disease has implications for therapeutic intervention Save
- Diverse Species-Specific Phenotypic Consequences of Loss of Function Sorting Nexin 14 Mutations Save
- Disruption of FOXF2 as a Likely Cause of Absent Uvula in an Egyptian Family. Save
- SNX14 mutations affect endoplasmic reticulum-associated neutral lipid metabolism in autosomal recessive spinocerebellar ataxia 20. Save
- Disruption to schizophrenia-associated gene Fez1 in the hippocampus of HDAC11 knockout mice. Save